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ABSTRACT: Preventing pregnancy in brucellosis-infected bison (Bison bison) provides a potential
means of preventing transmission of disease. To determine whether a gonadotropin-releasing
hormone (GnRH) vaccine was effective in reducing pregnancy in bison and to study the safety
of injecting GnRH in pregnant bison, a study was conducted at the Idaho Fish and Game Wildlife
Health Laboratory in Caldwell, Idaho (USA). Four pregnant and two nonpregnant female bison
were given a single injection of GnRH vaccine, and five pregnant adult females were given a
sham injection that contained only adjuvant. Three of the GnRH-vaccinated bison that were
pregnant at the time of vaccination delivered healthy calves. One treated bison had dystocia that
resulted in a dead calf. All control bison delivered healthy calves. After calving, females of both
groups were exposed to two bulls. Treated bison were palpated 6 wk after exposure to the bulls,
and blood was drawn for pregnancy-specific protein B analysis. The six treated bison were not
pregnant. The sham-treated bison became pregnant and delivered viable calves. This study dem-
onstrates that a single dose of GnRH vaccine is effective in preventing pregnancy in female bison
for at least 1 yr.
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INTRODUCTION
Bovine brucellosis, a bacterial disease
caused by Brucella abortus, is transmitted
among animals, including cattle, bison (Bi-
son bison), and elk (Cervus elaphus), pri-
marily through contact with infected
aborted fetuses, placentas, parturient flu-
ids, or postparturient uterine discharge.
Additionally, Brucella is shed in milk from
infected dams and can be transmitted to
calves through suckling. After initial infec-
tion, a dam often experiences abortion.
Subsequent pregnancies may result in
abortion or the birth of weak or normal
calves and may also result in the shedding
of B. abortus. The occurrence of venereal
transmission of brucellosis in bison is un-
known; however, on the basis of a single
study in bison (Robison et al., 1998) and
studies in cattle (Manthei et al., 1950;
Rankin, 1965), it is considered unlikely to
be a significant route of transmission.
Transmission of the disease in cattle, bi-
son, and elk, therefore, is primarily depen-
dent on the occurrence of pregnancy and
exposure to abortion or calving in infected
animals.
Rhyan et al. (2002) suggested that per-
manent sterilization, surgical or chemical,
is a disease-management strategy that
could be effectively used in Brucella-in-
fected bison to greatly reduce the possi-
bility of transmission to other animals. Bi-
son cows could remain persistently infect-
ed with B. abortus, and, as long as the in-
fected animals were not allowed to
become pregnant, they would not be likely
to transmit the infection. Therefore, dis-
ease prevalence might decrease dramati-
cally as that generation of infected bison
disappears. Objections have been raised to
permanent sterilization in relation to wild
horse immunocontraception, because it
might result in the permanent removal of
those animals from the gene pool and the
creation of a new ‘‘unnatural’’ class of an-
imals (Kirkpatrick and Turner, 1991).
The gonadotropin-releasing hormone
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(GnRH) vaccine is generally considered to
provide temporary sterilization, because
the reproductive activity of the target an-
imal returns as the GnRH antibody titer
drops below a protective level. This tem-
porary period of infertility may allow time
for B. abortus infection to clear.
The use of nonlethal methods to control
populations of pest animals is an area of
research that is receiving more interest
(Fagerstone et al., 2002). Kirkpatrick et al.
(1996) pioneered the use of porcine zona
pellucida (PZP) for use as a nonlethal,
contraceptive approach to pest animal
control. The difficulty with the use of PZP
in ungulates is that the animals that re-
ceive it, although they remain infertile,
continue to have estrous cycles. Female
white-tailed deer (Odocoileus virginianus)
vaccinated with PZP have continued to ex-
hibit sexual activity into February, 4 mo
beyond the normal breeding season (Mill-
er et al., 2000b). This continuous estrous
cycling results in increased activity during
early winter, at a time when the conser-
vation of calories is important, although
this increased cycling has not resulted in
any apparent health problems (Miller et
al., 2001). Additionally, it could increase
the spread of venereally transmitted dis-
eases, if present and, at least in the case
of deer in populated areas, may contribute
to increased collisions with automobiles.
Prolonging the breeding season of bison in
the greater Yellowstone area may be del-
eterious to the winter survival of dominant
bulls and vaccinated cows because of in-
creased activity during fall and early win-
ter.
Immunocontraception using the GnRH
vaccine is an alternative to PZP that would
not extend the breeding season. The key-
hole limpet hemocyanin–GnRH immuno-
contraceptive vaccine interferes with the
release of follicle-stimulating hormone
(FSH) and leutinizing hormone (LH),
thereby preventing normal function of the
ovaries and testes and their production of
progesterone and testosterone. Thus,
GnRH vaccine can effectively prevent
conception in either females or males (Tal-
war, 1985).
The GnRH vaccine has successfully pro-
duced sterility in Norway rats (Rattus
norvegicus; Miller et al., 1997) and white-
tailed deer (Miller et al., 2000a). The im-
munoneutralization of GnRH produces
temporary nonsurgical castration in ani-
mals (Meloen et al., 1994; Oonk et al.,
1998). In an ongoing study in female
white-tailed deer conducted by the Na-
tional Wildlife Research Center (Fort Col-
lins, Colorado, USA) and Pennsylvania
State University (University Park, Penn-
sylvania, USA), a single injection of GnRH
vaccine resulted in infertility lasting up to
3 yr.
The development of immunocontracep-
tives that are practical to use for wildlife
population control must include vaccine
delivery systems. Although the administra-
tion of an oral form of the vaccine may be
necessary in some situations, a long acting
single-shot injectable form of the vaccine
would have practical advantages over for-
mulations that require two injections. Im-
munocontraception has typically required
at least two doses, given as a prime and a
boost. The prime dose prepares the im-
mune system for a repeat antigen exposure
and provides only a short-term immune
response. The boost immunization can re-
sult in an immune response that may last
for months to years. To have success with
a single injection, the dose and timing of
the injection is more critical than when us-
ing two injections. This article reports on
the immunocontraception of penned bison
using the newly developed single-shot
GnRH vaccine.
MATERIALS AND METHODS
On 6 June 2002, six 6-yr-old female bison
were injected with 1,800 mg of a single-shot
GnRH vaccine (GonaCon/AdjuVacTM, devel-
oped by the National Wildlife Research Center,
United States Department of Agriculture, An-
imal Plant Health Inspection Service, Fort Col-
lins, Colorado—patent pending) in a 1-ml in-
jection given intramuscularly in the hip. Five
control bison were injected with the adjuvant,
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TABLE 1. Results of contraception in female bison using a GnRH vaccine.
Treatment
Year 1
Pregnancy status when
injected (June 2002)
Calving dates,
2002
Year 2
Pregnancy
rate PSPBa results
Calving dates,
2003
Sham injection 5/5 20 June–
26 July
5/5 5/5 positive
for pregnancy
4 June–29
July
1,800 mg GnRH/
AdjuVacb
4/6 28 June–1
July
0/6 0/6 positive
for pregnancy
No calves
born
a PSPB 5 pregnancy-specific protein B.
b GonaCon/AdjuVac, US Department of Agriculture, Animal Plant Health Inspection Service, patent pending.
FIGURE 1. Average serum progesterone levels and
anti-GnRH antibody titers for control bison cows.
1 ml, in the hip (control). All control bison and
four of the treated bison were pregnant at the
time of the injection. Because the GnRH vac-
cine has the potential to cause abortion, the
pregnant bison were vaccinated to determine
the safety of the GnRH vaccine. Blood samples
were drawn monthly for 4 mo and then every
other month for a total of 8 mo. Serum was
tested for progesterone by radioimmunoassay
and for GnRH antibody by enzyme-linked im-
munoassay (Miller et al., 2000a).
Two months after calving, a bull was intro-
duced to the pen and allowed to breed the
cows for 2.5 mo (17 September–1 December
2002). Six weeks after the bull was removed,
both control and GnRH-treated bison were
palpated for pregnancy diagnosis, and results
were confirmed by serum pregnancy-specific
protein B assay (PSPB) testing (Biotracking,
Moscow, Idaho).
RESULTS
Analysis of pregnancy and calving data
in the control and GnRH-treated bison at
the time of GnRH injection and the fol-
lowing year indicated that the GnRH vac-
cine was successful in reducing reproduc-
tion, compared with controls (Table 1). At
the time of vaccination, five of the sham-
treated cows and three of the six GnRH-
treated cows were in the last month of
pregnancy. Cows in both groups delivered
normal calves the first year; therefore, the
GnRH vaccine did not interfere with the
pregnancy. None of the GnRH-treated
cows became pregnant the year after the
vaccination. All control bison conceived,
and four had normal calves, with calving
dates of 4–30 June 2003. One control cow
died on 30 March 2003 but was pregnant
at the time of death. During this study, two
cows, one each in the treated and control
groups, had dystocia that resulted in dead
calves.
The average progesterone levels for
pregnant cows were the same for the treat-
ment and control groups at the start of the
study and after calving. After rebreeding,
the progesterone level of cows in the con-
trol group increased to pretreatment lev-
els, indicating that they became pregnant,
and anti-GnRH titers were not detected
(Fig. 1). Progesterone levels in the GnRH-
treated bison remained at nonpregnant
levels (Fig. 2). All control bison delivered
normal healthy calves and became preg-
nant again the second year. One of the five
control bison died from accidental causes
midgestation. The remaining four controls
had normal calves in year 2 of the study.
Three of the six GnRH-treated bison
were in late gestation when they were im-
munized, and all delivered normal calves
within 1 mo after treatment. Two of the
GnRH-treated cows were not pregnant at
the time of GnRH vaccination, as suggest-
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FIGURE 2. Average anti-GnRH antibody titers and
serum progesterone levels in bison cows vaccinated
late during pregnancy.
FIGURE 3. Average anti-GnRH antibody titers and
serum progesterone levels in bison cows vaccinated
when not pregnant.
ed by low progesterone levels at the time
of treatment (Fig. 3). The low progester-
one values during the postpartum period
in the cows that calved were comparable
to those of the control cows. However,
they did not become pregnant after ex-
posure to the bulls, as indicated by low
progesterone levels, the absence of a fetus
on palpation, and negative PSPB serum
test results.
An exception to the results of treatment
of cows during late pregnancy was bison
B-40, which had been given the GnRH
vaccine during midpregnancy. This bison
cow was injected with the vaccine on 6
June 2002 and delivered full term on 6
November 2002, with dystocia, resulting in
a dead calf. The progesterone level pro-
gressively dropped from 7.0–3.5 mg/ml of
serum during the first 2 mo after vacci-
nation and leveled off at 3.4 mg/ml of se-
rum during the third month, 2 mo before
the birth of the dead full-term calf. This
cow had a positive PSPB result, low pro-
gesterone levels, and was not pregnant on
palpation.
The anti-GnRH data in treated bison in-
dicated that a protective antibody titer was
reached by the first time blood was col-
lected (47 days after vaccination). The
mean titer at this time was 112,000, de-
creasing to a mean titer of 72,000 by the
end of the study. Antibody titers of 64,000
or greater have been shown to be consis-
tent with contraception (Miller et al.,
2000a).
In the beginning of the study, similar
progesterone and PSPB levels in control
and treated groups suggested that cows in
both groups were pregnant. Calving dates
were comparable in the control and treat-
ed cows, indicating synchronous breeding
cycles (Table 1). However, in the second
year, elevations in progesterone levels in
the control group suggested that they be-
came pregnant, and low progesterone lev-
els in the treated group suggested infertil-
ity (Figs. 1–3).
DISCUSSION
The GnRH vaccine induces infertility in
female mammals by reducing the release
of FSH and LH, which, in turn, interferes
with either the normal estrous or ovulatory
cycle or reduces progesterone concentra-
tion during early pregnancy, which may in-
terfere with maintenance of pregnancy.
Stevenson (1997) stated that GnRH con-
trols the amount of progesterone pro-
duced by the corpus luteum (CL), which
maintains pregnancy for 200 days of the
mean 280-day gestation in cattle. After 200
days, the ovary containing the CL can be
removed without interfering with pregnan-
cy, which indicates that pregnancy is not
maintained by pituitary GnRH; the pla-
centa apparently takes over the production
and maintenance of progesterone. Bison
have a gestation period similar to that of
cattle.
Our results indicate that the GnRH vac-
cine can be administered safely during the
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last third of pregnancy. Protective levels of
anti-GnRH antibody require 30–45 days to
develop, which suggests that the vaccine
could be safely administered at $170 days
of gestation without negative effects on the
fetus. This was shown to be the case in the
three bison treated late in pregnancy.
One cow was vaccinated during the sec-
ond trimester of pregnancy and delivered
a full-term dead calf on 6 November. It is
unknown whether the GnRH vaccine con-
tributed to death the fetus. There was a
decrease in progesterone levels in this cow
after vaccination that could have contrib-
uted to the loss of viability of the calf. Be-
cause the bull was with the cows from 17
September to 1 December, it is unlikely
that this cow could have rebred. However,
anti-GnRH antibody titers were sufficient
in this cow to prevent pregnancy. One con-
trol bison also had a similar late full-term
dead calf; thus, it is uncertain whether the
vaccine caused the death of the calf in the
vaccinated cow.
All control and treated cows were tested
for pregnancy by palpation and serum pro-
gesterone and PSBP levels during Febru-
ary 2003. Bison B-40 had a positive serum
PSPB test at this time but a low proges-
terone level and was not pregnant on pal-
pation. Thus, the PSPB test was incorrect.
This is consistent with reports that re-
tained placentas following abortions can
cause a false-positive PSPB result for sev-
eral months (Sasser et al., 1986). The bi-
son will be monitored for 2 more years to
determine the duration of the contracep-
tive effect.
This study demonstrates that a single in-
jection of GnRH vaccine is effective in
preventing contraception in female bison
for at least 1 yr. Booster injections length-
en the contraceptive effect in white-tailed
deer (Miller and Killian, 2000), and
lengthening the contraceptive effect in bi-
son may be achieved similarly. Use of the
GnRH vaccine in Brucella-infected bison
should effectively reduce transmission of
disease by reducing pregnancy rates and
subsequent abortion or parturition.
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